Baidu
map

有关MedSci资讯保护原创者版权的声明

2015-02-05 MedSci MedSci原创

首先,应该就是保护版权的这是一个大前提,只有保护版权,行业才能健康有序地发展。其次,MedSci也看到互联网上有大量不尊重版权的事实。大量MedSci原创稿件被未授权转载,甚至转载时抹去作者和来源信息。MedSci一直呼吁以及坚持尊重版权意识。MedSci早在2012年在业内率先提出转载时尊重版权的声明,并一直屡行://www.sandwebs.com/article/show_article.do?

绿色的版权符号

首先,应该就是保护版权的这是一个大前提,只有保护版权,行业才能健康有序地发展。

其次,MedSci也看到互联网上有大量不尊重版权的事实。大量MedSci原创稿件被未授权转载,甚至转载时抹去作者和来源信息。MedSci一直呼吁以及坚持尊重版权意识。MedSci早在2012年在业内率先提出转载时尊重版权的声明,并一直屡行://www.sandwebs.com/article/show_article.do?id=e75c44989f 。在2014年,我们再次加强声明://www.sandwebs.com/article/show_article.do?id=1d913650657 ,进一步加强版权保护。我们希望以我们的态度,为医学专业互联网提供一个越来越干净,透明的空间。

下一步,MedSci在以往坚持学术,尊重版权的前提下,进一步提高原创比例,以及加大对原创的支持与奖励,维护原作者的利益。

当然,MedSci做所做的一切目的都是为了学医生,为了传播医学临床学术,传播医学进展。同时,MedSci 作为一个平台,提供医生、机构一个重要信息发布平台,让更多医生能接触到这些信息,与同道有更充分的交流互动。如果有医生或平台愿意加入合作,我们愿意提供各种形式的增值服务。也希望有更多的医生同道贡献原创的内容。

如果愿意给MedSci投稿,建议关注MedSci官方微信:MedSci_cn,然后与我们联系。

MedSci编辑部
2015.2.5

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2085085, encodeId=ef19208508545, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Sep 27 18:21:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15591, encodeId=737815591fc, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15592, encodeId=ae88155927d, content=赞成, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606400, encodeId=519b160640055, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Feb 07 10:21:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15193, encodeId=57d21519333, content=支持MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:50:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2085085, encodeId=ef19208508545, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Sep 27 18:21:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15591, encodeId=737815591fc, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15592, encodeId=ae88155927d, content=赞成, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606400, encodeId=519b160640055, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Feb 07 10:21:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15193, encodeId=57d21519333, content=支持MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:50:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-16 jianlion

    支持

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2085085, encodeId=ef19208508545, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Sep 27 18:21:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15591, encodeId=737815591fc, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15592, encodeId=ae88155927d, content=赞成, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606400, encodeId=519b160640055, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Feb 07 10:21:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15193, encodeId=57d21519333, content=支持MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:50:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-16 jianlion

    赞成

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2085085, encodeId=ef19208508545, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Sep 27 18:21:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15591, encodeId=737815591fc, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15592, encodeId=ae88155927d, content=赞成, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606400, encodeId=519b160640055, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Feb 07 10:21:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15193, encodeId=57d21519333, content=支持MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:50:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2085085, encodeId=ef19208508545, content=<a href='/topic/show?id=26651150528' target=_blank style='color:#2F92EE;'>#MedSci资讯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11505, encryptionId=26651150528, topicName=MedSci资讯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b09892, createdName=qidongfanjian, createdTime=Sun Sep 27 18:21:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15591, encodeId=737815591fc, content=支持, beContent=null, objectType=article, channel=null, level=null, likeNumber=118, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15592, encodeId=ae88155927d, content=赞成, beContent=null, objectType=article, channel=null, level=null, likeNumber=168, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=928e1615200, createdName=jianlion, createdTime=Mon Feb 16 08:30:00 CST 2015, time=2015-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606400, encodeId=519b160640055, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Feb 07 10:21:00 CST 2015, time=2015-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=15193, encodeId=57d21519333, content=支持MedSci, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=175.8.168.**, createdTime=Thu Feb 05 22:50:00 CST 2015, time=2015-02-05, status=1, ipAttribution=)]
    2015-02-05 175.8.168.**

    支持MedSci

    0

相关资讯

11.11 MedSci 大活动---你来,就送

还在为积分不够而发愁吗,还在为没获得纪念版T恤而黯然神伤吗,只要你来,就有得送。 活动内容; 1,转发此微信,直接获得22个积分 2,转发到微信,微博并推荐10个好友关注,以下奖品任你选。 活动形式: 转发后,直接截图给我们,并留下您的联系方式(姓名+联系电话+邮箱+邮寄地址)  

疯狂开学party——“自定义”话题

疯狂开学party——“自定义”话题

疯狂开学party——“交流”话题

疯狂开学party——“交流”话题

学霸的神器--MedSci资讯APP使用手册

工欲善其事,必先利其器! 这年头做科研,没个秘密武器怎么混? MedSci倾力打造最新APP,以资讯为载体,集合各大医学工具,审度最新临床研究,挑战世界医学难题,让您科研之旅不那么一般! 说再多不如一键安装自己来体验! 首页展示:医学快讯实时更新,分科资讯目标精准。全站文章,在登陆条件下评论即可+2积分(PC端网站积分+1) 功能菜单:右侧功能菜单,包括MedSc

重磅推出:MedSci APP上线啦!

MedSci APP 上线啦!MedSci APP 专为医学科研者定制的阅读APP。在这里,不仅有最新的临床医学循证信息,更有丰富实用的科研工具,为您展开不一样的科研旅程,使用更方便快捷 2015年,我们 MedSci APP正式上线啦,MedSci APP 结合了网页版所包含的所有内容,还增加了许多新功能,使用更方便快捷。感谢大家对MedSci的支持与关注,小编在此解说一下如何下载Me

疯狂开学party——吐槽君专区

如果您是吐槽君,请务必来这里。如果吐槽能转化成能量,我将无所不能。 任务描述:学习生活工作中,总有一些不那么如意,悲催的事,似乎那些不如意的事更占篇幅。那么请来这里,一句话表达那些能让您嘴角抽搐或者想重新思考人生的事!

Baidu
map
Baidu
map
Baidu
map